Of the 27 proteins that were significantly differentially expressed in both cohorts of serum, 11 proteins were found at decreased levels in ovarian cancer samples compared to the healthy controls, including the two proteins in our multiprotein classifier, ITGAV and SEZ6L. Here, SEZ6L is linked to ovarian carcinoma.